Skip to main content
logo
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.700
-0.010 (-0.21%)
Oct 27, 2025, 3:49 PM EDT

BioStem Technologies Revenue

BioStem Technologies had revenue of $49.30M in the quarter ending June 30, 2025, a decrease of -33.82%. This brings the company's revenue in the last twelve months to $307.26M, up 133.77% year-over-year. In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth.

Revenue (ttm)
307.26M
Revenue Growth
+133.77%
P/S Ratio
0.26
Revenue / Employee
9.31M
Employees
33
Market Cap
79.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024301.83M285.14M1,708.93%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017313.45K-293.78K-48.38%
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

BioStem Technologies News

More News